ACE Inhibitor, Angiotensin II Receptor Blockers, and ApoE4 on Alzheimer's

 
   Lead Investigator:    Wendy Qiu
   Institution      :    Boston University
   E-Mail           :    wqiu67@bu.edu
   Proposal ID      :    313


   Publications:


1  Qiu WQ, Mwamburi M,  Besser LM , Zhu H, Li H, Wallack M,  Phillips L , Qiao L, Budson AE, Stern R, Kowall N
   Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer's disease in the Absence of Apoliprotein E4 allele
   Journal Article  J Alzheimers Dis,37:421-428,2013,PMC3873370

   PUBLISHED



2  Wallack M, Zhu H, Mwamburi M,  Phillips LE , Budson A, Kowall N, Stern R, Qiu WQ
   Apolipoprotein E Allele, Angiotensin-Converting Enzyme and its inhibitors, in the Development of Alzheimer's Disease
   Abstract  Alzheimers Dement,9:P616-617,2013,

   PUBLISHED





   Proposal Description:
   This is a follow-up to our previous study on ACE inhibitors and APOE e4 and AD (in press) to study if ACE inhibitor plus its receptor blocker (ARBs) can further reduce the AD risk.